0001727073-19-000001.txt : 20190712 0001727073-19-000001.hdr.sgml : 20190712 20190712090406 ACCESSION NUMBER: 0001727073-19-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20190712 DATE AS OF CHANGE: 20190712 EFFECTIVENESS DATE: 20190712 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Cage Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001727073 IRS NUMBER: 823580434 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-344121 FILM NUMBER: 19952135 BUSINESS ADDRESS: STREET 1: 500 E. PRATT STREET STREET 2: SUITE 1200 CITY: BALTIMORE STATE: MD ZIP: 21202 BUSINESS PHONE: 917-733-1542 MAIL ADDRESS: STREET 1: 500 E. PRATT STREET STREET 2: SUITE 1200 CITY: BALTIMORE STATE: MD ZIP: 21202 D 1 primary_doc.xml X0708 D LIVE 0001727073 Cage Pharmaceuticals, Inc. 500 E. PRATT STREET SUITE 1200 BALTIMORE MD MARYLAND 21202 917-733-1542 DELAWARE None None Corporation true 2017 Jason Rifkin 14 Oak Lane Scarsdale NY NEW YORK 10583 Executive Officer Other Health Care Decline to Disclose 06b false 2019-07-10 false true false 0 480000 480000 0 false 1 0 0 0 false Cage Pharmaceuticals, Inc. Jason Rifkin Jason Rifkin President and CEO 2019-07-12